R-spondin 3
R-spondin 3 (RSPO3) is a protein that in humans is encoded by the RSPO3 gene. It is a member of the R-spondin family, which are secreted proteins characterized by two cysteine-rich, furin-like domains and one thrombospondin type 1 domain. R-spondins act as ligands for the LGR4-6 receptors and are involved in the regulation of the Wnt signaling pathway, a critical pathway for cell development, proliferation, and differentiation. The Wnt pathway plays a significant role in embryonic development, adult tissue homeostasis, and various diseases, including cancer.
Function[edit]
R-spondin 3 is involved in the potentiation of Wnt signaling, which is essential for various developmental processes. It binds to LGR4-6 receptors, leading to the activation of the Wnt/β-catenin signaling pathway. This activation results in the accumulation of β-catenin in the cytoplasm and its subsequent translocation into the nucleus, where it influences the expression of Wnt target genes. RSPO3 has been implicated in the development of organs such as the lungs and intestines and plays a role in the regeneration of tissues and the maintenance of stem cells.
Clinical Significance[edit]
Alterations in the expression or function of RSPO3 have been associated with several diseases. Overexpression of RSPO3 has been observed in certain types of cancer, including colorectal and ovarian cancers, suggesting a role in tumorigenesis. Conversely, reduced expression of RSPO3 may be involved in the pathogenesis of diseases characterized by impaired tissue regeneration or degeneration.
Genetics[edit]
The RSPO3 gene is located on human chromosome 6q22.1. Variants and mutations within this gene have been studied for their association with disease susceptibility and response to therapies, particularly in the context of cancer.
Research[edit]
Research on R-spondin 3 has focused on its potential therapeutic applications, especially in regenerative medicine and cancer treatment. Its ability to enhance Wnt signaling makes it a candidate for promoting tissue regeneration and repair. In oncology, understanding the mechanisms by which RSPO3 contributes to tumor growth and progression may lead to novel therapeutic targets.

This article is a biochemistry stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
